HOUSTON, July 17, 2007 (PRIME NEWSWIRE) -- In connection with the matters discussed in the press release of June 15, Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced it has retained the investment banking firm of Morgan Stanley to assist in evaluating its strategic alternatives to maximize stockholder value.
